Details for New Drug Application (NDA): 205013
✉ Email this page to a colleague
The generic ingredient in CAFFEINE CITRATE is caffeine citrate. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the caffeine citrate profile page.
Summary for 205013
Tradename: | CAFFEINE CITRATE |
Applicant: | Eugia Pharma |
Ingredient: | caffeine citrate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 205013
Physiological Effect | Central Nervous System Stimulation |
Medical Subject Heading (MeSH) Categories for 205013
Suppliers and Packaging for NDA: 205013
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CAFFEINE CITRATE | caffeine citrate | SOLUTION;INTRAVENOUS | 205013 | ANDA | AuroMedics Pharma LLC | 55150-187 | 55150-187-03 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-187-03) / 3 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 30MG BASE/3ML (EQ 10MG BASE/ML) | ||||
Approval Date: | Sep 22, 2015 | TE: | AP | RLD: | No |
Complete Access Available with Subscription